ClinicalTrials.gov record
ARI103094-Follow-Up Study for REDUCE Study Subjects
ClinicalTrials.gov ID: NCT00883909
Public ClinicalTrials.gov record NCT00883909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00883909
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 2,795 participants
Conditions and interventions
Conditions
Interventions
- dutasteride Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2009
- Primary completion
- Nov 30, 2010
- Completion
- Dec 28, 2010
- Last update posted
- Jul 10, 2017
2009 – 2010
United States locations
- U.S. sites
- 73
- U.S. states
- 31
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Anchorage | Alaska | 99508 | — |
| GSK Investigational Site | Phoenix | Arizona | 85032 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72211 | — |
| GSK Investigational Site | Anaheim | California | 92801 | — |
| GSK Investigational Site | La Mesa | California | CA 91942 | — |
| GSK Investigational Site | Laguna Hills | California | 92653 | — |
| GSK Investigational Site | Los Angeles | California | 90048 | — |
| GSK Investigational Site | Los Angeles | California | 90073 | — |
| GSK Investigational Site | Poway | California | 92064 | — |
| GSK Investigational Site | San Bernardino | California | 92404 | — |
| GSK Investigational Site | San Diego | California | 92120 | — |
| GSK Investigational Site | Tarzana | California | 91356 | — |
| GSK Investigational Site | Torrance | California | 90505 | — |
| GSK Investigational Site | Denver | Colorado | 80211 | — |
| GSK Investigational Site | Englewood | Colorado | 80113 | — |
| GSK Investigational Site | Longmont | Colorado | 80501 | — |
| GSK Investigational Site | New Britain | Connecticut | 06052 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20307 | — |
| GSK Investigational Site | Longwood | Florida | 32750 | — |
| GSK Investigational Site | Orlando | Florida | 32803 | — |
| GSK Investigational Site | Pinecrest | Florida | 33156 | — |
| GSK Investigational Site | Pinellas Park | Florida | 33782 | — |
| GSK Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| GSK Investigational Site | Galesburg | Illinois | 61401 | — |
| GSK Investigational Site | Fort Wayne | Indiana | 46825 | — |
| GSK Investigational Site | Greenwood | Indiana | 46143 | — |
| GSK Investigational Site | Jeffersonville | Indiana | 47130 | — |
| GSK Investigational Site | Overland Park | Kansas | 66211 | — |
| GSK Investigational Site | Wichita | Kansas | 67208 | — |
| GSK Investigational Site | Annapolis | Maryland | 21401 | — |
| GSK Investigational Site | Towson | Maryland | 21204 | — |
| GSK Investigational Site | Boston | Massachusetts | 02115 | — |
| GSK Investigational Site | Watertown | Massachusetts | 02472 | — |
| GSK Investigational Site | Royal Oak | Michigan | 48073 | — |
| GSK Investigational Site | Saint Joseph | Michigan | 49085 | — |
| GSK Investigational Site | Chaska | Minnesota | 55318 | — |
| GSK Investigational Site | Sartell | Minnesota | 56377 | — |
| GSK Investigational Site | Kansas City | Missouri | 64114 | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | St Louis | Missouri | 63110 | — |
| GSK Investigational Site | Omaha | Nebraska | 68114 | — |
| GSK Investigational Site | West Orange | New Jersey | 07052 | — |
| GSK Investigational Site | Albany | New York | 12208 | — |
| GSK Investigational Site | Garden City | New York | 11530 | — |
| GSK Investigational Site | Great Neck | New York | 11021 | — |
| GSK Investigational Site | New York | New York | 10016 | — |
| GSK Investigational Site | Poughkeepsie | New York | 12601 | — |
| GSK Investigational Site | Staten Island | New York | 10304 | — |
| GSK Investigational Site | Syracuse | New York | 13210 | — |
| GSK Investigational Site | Cary | North Carolina | 27518 | — |
| GSK Investigational Site | Greenville | North Carolina | 27834 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27607 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45219 | — |
| GSK Investigational Site | Columbus | Ohio | 43214 | — |
| GSK Investigational Site | Sheffield | Ohio | 44035 | — |
| GSK Investigational Site | Ponca City | Oklahoma | 74601 | — |
| GSK Investigational Site | Portland | Oregon | 97205 | — |
| GSK Investigational Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| GSK Investigational Site | Lancaster | Pennsylvania | 17604 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19144 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19152 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| GSK Investigational Site | State College | Pennsylvania | 16801 | — |
| GSK Investigational Site | Providence | Rhode Island | 02904 | — |
| GSK Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| GSK Investigational Site | Simpsonville | South Carolina | 29681 | — |
| GSK Investigational Site | Nashville | Tennessee | 37232 5770 | — |
| GSK Investigational Site | Norfolk | Virginia | 23502 | — |
| GSK Investigational Site | Richmond | Virginia | 23249 | — |
| GSK Investigational Site | Virginia Beach | Virginia | 23454 | — |
| GSK Investigational Site | Seattle | Washington | 98166 | — |
| GSK Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 194 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00883909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00883909 live on ClinicalTrials.gov.